ÂÜÀòÂÒÂ×

Raven Jaeger serves as the Chief Regulatory Officer at CalciMedica since May 2023, following a similar role at Diffusion Pharmaceuticals from May 2022 to May 2023, where responsibilities included developing regulatory strategies for innovative therapies targeting hypoxic tumors. Raven has extensive experience in regulatory affairs, holding senior positions such as Sr. Vice President at both ML BioSolutions and Origin Biosciences from January 2021 to May 2022, and Vice President at Origin Biosciences from April 2018 to January 2021. Prior experience includes a Director role at Leadiant Biosciences from 2011 to April 2018, Manager roles at ICON Clinical Research and ICON Development Solutions, and a Sr. Associate position at Nabi. Raven's educational background includes degrees in Biology, Biotechnology Management, and Natural Sciences from institutions such as The Johns Hopkins University and the University of Maryland University College.